New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
April 25, 2023 10:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
ONWARD erhält weitere FDA Breakthrough Device Designations für Blasenkontrolle, Linderung von Spastiken und Blutdruckregulation nach Rückenmarksverletzung
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD reçoit de nouvelles désignations de dispositifs révolutionnaires de la FDA pour le contrôle de la vessie, le soulagement de la spasticité et la régulation de la pression artérielle après une lésion de la moelle épinière
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 23 févr. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext : ONWD), société de technologie médicale créant des thérapies...
ONWARD ontvangt nieuwe FDA Breakthrough Device Designations voor blaascontrole, vermindering van spasticiteit en bloeddrukregeling bij dwarslaesiepatiënten
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), ONWARD Medical N.V. (Euronext: ONWD), het medische...
ONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative...
Neurotech Devices Global Market Outlook Report 2023: Market Revenue Data for 2021, Estimates for 2022, 2023, 2025, and CAGR Projections through 2027
February 14, 2023 09:38 ET
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based...
Global Intraoperative Neuromonitoring (IONM) Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
January 19, 2023 04:58 ET
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer’s Disease
October 25, 2022 07:15 ET
|
Sinaptica Therapeutics
Phase II sham-controlled randomized trial met its primary endpoint with statistical significance; treatment slowed cognitive decline by 82% over 6 months in the treated population compared to sham...
The Worldwide Neurostimulation Devices Industry is Expected to Reach $17.3 Billion by 2030
August 22, 2022 06:23 ET
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Neurostimulation Devices Market, by Device Type, by Application, by End-user, Estimation & Forecast, 2017-2030" report has been added to...
neurocare group AG obtains patent grant on treatment method for neuromodulation in Japan
June 23, 2022 11:00 ET
|
neurocare group AG
MUNICH, June 23, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...